Merck and Sinopharm to Set Up Vaccine JV
July 27, 2010 at 13:00 PM EDT
Merck Sharp & Dohme (MSD), the international arm of US big pharma Merck, signed a letter of mutual intent with Sinopharm (China National Pharmaceutical Group Corporation) to cooperate on a vaccine for human papillomavirus (HPV). HPV, if left untreated, can cause cervical cancer. The two companies plan to establish a joint venture. More details.... Stock Symbols: (NYSE: MRK) (SHEX: 600511)